How GLP-1 drugs reshape fat and metabolism
Part of Hormones & metabolism clinical trials.
This study compares how a GLP-1 medication (a drug that helps control blood sugar and weight) changes the way your body stores and uses fat. Researchers will use imaging scans to see these changes over time in people with metabolic syndrome—a cluster of health conditions including high blood pressure, high cholesterol, and excess weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 20–65 years old
- BMI of 27 or higher (overweight or obese) with metabolic syndrome (high blood pressure, high cholesterol, and/or high blood sugar in a pattern doctors recognize)
- Stable doses of blood-pressure or cholesterol medications for at least 3 months
- No personal or family history of medullary thyroid cancer, MEN2 syndrome, pancreatitis, or diabetes
- Kidney and liver function well enough to safely participate (eGFR ≥30, no severe liver disease)
- No recent heart attack, stroke, or heart procedure in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to manage weight: taking a GLP-1 medication (like tirzepatide or semaglutide) versus making lifestyle changes without medication. It will help researchers learn which approach works best for people with overweight or obesity.
This trial compares different ways to keep weight off after you've lost weight using a GLP-1 medication, like semaglutide or tirzepatide. It tests reducing your GLP-1 dose and adding other weight loss medications to help maintain your progress.
This study looks at how GLP-1 receptor agonist drugs (used for weight loss) affect muscle mass and strength in people with obesity who do not have diabetes. It may help understand if these medications impact muscle health.
This study tests whether a weight-loss medication (a GLP-1 agonist) can change how the brain works and help with long-term weight control. It involves brain scans and a closely monitored treatment plan.
This study is looking at how certain diabetes medications affect the body's makeup (like muscle and fat) and how the body works, using special imaging scans. It may help doctors understand these treatments better and could guide future care.
This study tests whether a GLP-1 receptor agonist (a type of medicine that helps control blood sugar and appetite) can improve metabolic health in people with early type 1 diabetes. It may be an option if you have already taken teplizumab to delay the disease or were recently diagnosed with type 1 diabetes.
Hear when a new Obesity and Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.